11 – 20 of 657
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Vägar till svensk legitimation för läkare utbildade i tredje land
- Contribution to journal › Article
-
Mark
Real-world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes
- Contribution to journal › Article
-
Mark
Thrombotic risk determined by ABO, F8, and VWF variants in a population-based cohort study
- Contribution to journal › Article
-
Mark
Fibrinogen genotypes and their impact on recurrence of venous thromboembolism and family history : A prospective population-based study
- Contribution to journal › Article
- 2024
-
Mark
Future needs for continuing innovation in hemophilia : improving outcomes for individuals of all severities, including women and those in resource-constrained regions
- Contribution to journal › Scientific review
-
Mark
Recombinant FVIII replacement products for haemophilia A : An updated valuation by indirect comparison measuring area under the curve
- Contribution to journal › Debate/Note/Editorial
-
Mark
Tissue factor (F3) gene variants and thrombotic risk among middle-aged and older adults : A population-based cohort study
- Contribution to journal › Article
-
Mark
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B.
- Contribution to journal › Article
-
Mark
Low bleeding rates after intramuscular Covid-19 vaccination in patients with haemophilia and von Willebrand disease : Outcome data from the Swedish haemophilia registry
- Contribution to journal › Debate/Note/Editorial
-
Mark
Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria
- Contribution to journal › Article
